ArticleOncotarget2020

Biomarker analysis to predict the pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer: An exploratory biomarker study of COMPASS, a randomized phase II trial.

Takashi Oshima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.